{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:13:16Z","timestamp":1790399596583,"version":"4.1.0"},"reference-count":176,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01443","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T02:49:24Z","timestamp":1594694964000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":181,"title":["Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects"],"prefix":"10.3389","volume":"11","author":[{"given":"Raisa","family":"Kraaijvanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Janssen Bon\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane D. M.","family":"Vorselaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","article-title":"Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) Adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999","volume":"160","author":"Statement","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"102462","DOI":"10.1016\/j.autrev.2020.102462","article-title":"Immune response biomarkers as indicators of sarcoidosis presence, prognosis, and possible treatment: an Immunopathogenic perspective","volume":"19","author":"Tarasidis","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1701124","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17","volume":"51","author":"Broos","year":"2018","journal-title":"Eur Respir J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1038\/s41598-017-04109-6","article-title":"Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1378\/chest.121.1.32","article-title":"Mortality of intrathoracic sarcoidosis in referral vs population-based settings: Influence of stage, ethnicity, and corticosteroid therapy","volume":"121","author":"Reich","year":"2002","journal-title":"Chest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3238\/arztebl.2016.0565","article-title":"The diagnosis, differential diagnosis, and treatment of sarcoidosis","volume":"113","author":"Prasse","year":"2016","journal-title":"Dtsch Aerzteblatt Online."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/1744666X.2019.1568240","article-title":"Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis","volume":"15","author":"Ramos-Casals","year":"2019","journal-title":"Expert Rev Clin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"68","author":"Atkinson","year":"2001","journal-title":"Clin Pharmacol Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev Clin Immunol."},{"key":"B11","first-page":"219","article-title":"Biomarkers in sarcoidosis","volume-title":"Sarcoidosis A Clinician's Guide","author":"Schimmelpennink","year":"2019"},{"key":"B12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccm.2015.08.016","article-title":"Cellular players in the immunopathogenesis of sarcoidosis","volume":"36","author":"Zissel","year":"2015","journal-title":"Clin Chest Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"458","DOI":"10.12659\/PJR.897708","article-title":"Serum ACE level in sarcoidosis patients with typical and atypical HRCT manifestation","volume":"81","author":"Kahkouee","year":"2016","journal-title":"Polish J Radiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/0002-9343(75)90395-2","article-title":"Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosis","volume":"59","author":"Lieberman","year":"1975","journal-title":"Am J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1378\/chest.107.3.706","article-title":"Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD","volume":"107","author":"Brice","year":"1995","journal-title":"Chest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1164\/ajrccm.159.4.9806106","article-title":"Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease","volume":"159","author":"Maier","year":"1999","journal-title":"Am J Respir Crit Care Med."},{"key":"B17","first-page":"54","article-title":"Serum angiotensin\u2013converting enzyme (SACE) in sarcoidosis and other granulomatous disorders","volume":"95","author":"Studdy","year":"1978","journal-title":"Trans Med Soc Lond."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.249.14.1888","article-title":"Serum Angiotensin Converting Enzyme Activity in Patients With Histoplasmosis","volume":"249","author":"Ryder","year":"1983","journal-title":"JAMA J Am Med Assoc."},{"key":"B19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.rmed.2006.06.025","article-title":"ACE I\/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis","volume":"101","author":"Kruit","year":"2007","journal-title":"Respir Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00408-019-00219-2","article-title":"Identification of active sarcoidosis using chitotriosidase and angiotensin-converting enzyme","volume":"197","author":"Lopes","year":"2019","journal-title":"Lung."},{"key":"B21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"Vorselaars","year":"2015","journal-title":"Respir Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: Epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1378\/chest.15-1061","article-title":"Ordering of the serum angiotensin-converting enzyme test in patients receiving angiotensin-converting enzyme inhibitor th erapy an avoidable but common error","volume":"148","author":"Krasowski","year":"2015","journal-title":"Chest."},{"key":"B24","doi-asserted-by":"publisher","first-page":"12537","DOI":"10.1074\/jbc.274.18.12537","article-title":"Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity","volume":"274","author":"Majcherczyk","year":"1999","journal-title":"J Biol Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8565423","article-title":"Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6","volume":"2019","author":"Bergantini","year":"2019","journal-title":"Dis Markers."},{"key":"B26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/PL00007637","article-title":"Serum lysozyme levels and clinical features of sarcoidosis","volume":"177","author":"Tomita","year":"1999","journal-title":"Lung."},{"key":"B27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00011-003-1181-9","article-title":"Potential role of immune system activation-associated production of neopterin derivatives in humans","volume":"52","author":"Hoffmann","year":"2003","journal-title":"Inflamm Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/biom8030084","article-title":"YKL-40, soluble IL-2 receptor, angiotensin converting enzyme and C-reactive protein: comparison of markers of sarcoidosis activity","volume":"8","author":"Gelisgen","year":"2018","journal-title":"Biomolecules."},{"key":"B29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1183\/09031936.03.00010403","article-title":"Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis","volume":"21","author":"Ziegenhagen","year":"2003","journal-title":"Eur Respir J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1046\/j.1365-2249.1999.01071.x","article-title":"Neopterin-induced expression of intercellular adhesion molecule-1 (ICAM-1) in type II-like alveolar epithelial cells","volume":"118","author":"Hoffmann","year":"1999","journal-title":"Clin Exp Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00408-014-9647-9","article-title":"Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias","volume":"192","author":"Korthagen","year":"2014","journal-title":"Lung."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.rmed.2006.12.006","article-title":"A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker","volume":"101","author":"Kruit","year":"2007","journal-title":"Respir Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.rmed.2004.09.016","article-title":"Increased serum YKL-40 in patients with pulmonary sarcoidosis - a potential marker of disease activity?","volume":"99","author":"Johansen","year":"2005","journal-title":"Respir Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1189\/jlb.0706428","article-title":"Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors","volume":"81","author":"Weaver","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00365513.2011.626868","article-title":"Soluble CD163","volume":"72","author":"M\u00f8ller","year":"2012","journal-title":"Scand J Clin Lab Invest."},{"key":"B36","unstructured":"Serum levels of soluble CD163 as a useful marker of macrophage\/monocyte activity in sarcoidosis patients99105\n            TanimuraH\n            MizunoK\n            OkamotoH\n          26278688Sarcoidosis Vasc Diffus Lung Dis.322015"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1089\/ars.2012.4834","article-title":"CD163 and inflammation: biological, diagnostic, and therapeutic aspects","volume":"18","author":"Etzerodt","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"B38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cca.2009.09.034","article-title":"Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis","volume":"411","author":"Boot","year":"2010","journal-title":"Clin Chim Acta."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.rmed.2013.06.004","article-title":"CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases","volume":"107","author":"Sixt","year":"2013","journal-title":"Respir Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am J Respir Crit Care Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"Eklund","year":"2012","journal-title":"Crit Rev Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.rmed.2010.12.010","article-title":"Analysis of serum amyloid A in sarcoidosis patients","volume":"105","author":"Bargagli","year":"2011","journal-title":"Respir Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1055\/s-0037-1603087","article-title":"Etiology and immunopathogenesis of sarcoidosis: novel insights","volume":"38","author":"Beijer","year":"2017","journal-title":"Semin Respir Crit Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0173304","DOI":"10.1371\/journal.pone.0173304","article-title":"Serum amyloid A, protein Z, and C4b-binding protein \u03b2 chain as new potential biomarkers for pulmonary tuberculosis","volume":"12","author":"Jiang","year":"2017","journal-title":"PLoS One."},{"key":"B45","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1515\/jomb-2016-0017","article-title":"Verifying sarcoidosis activity: chitotriosidase versus ACE in sarcoidosis - a case-control study","volume":"35","author":"Popevi\u0107","year":"2016","journal-title":"J Med Biochem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10875-012-9754-4","article-title":"Human chitotriosidase: a sensitive biomarker of sarcoidosis","volume":"33","author":"Bargagli","year":"2013","journal-title":"J Clin Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1346-8138.2003.tb00424.x","article-title":"Circulating CD14+CD16+ monocytes are expanded in sarcoidosis patients","volume":"30","author":"Okamoto","year":"2003","journal-title":"J Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1183\/13993003.00709-2016","article-title":"Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?","volume":"48","author":"Hijdra","year":"2016","journal-title":"Eur Respir J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1365-2249.1998.00617.x","article-title":"Selective depletion of CD14+CD16+ monocytes by glucocorticoid therapy","volume":"112","author":"Fingerle-Rowson","year":"1998","journal-title":"Clin Exp Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1378\/chest.08-0443","article-title":"Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis","volume":"134","author":"Heron","year":"2008","journal-title":"Chest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/cyto.b.20031","article-title":"Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels","volume":"63","author":"Davis","year":"2005","journal-title":"Cytom Part B Clin Cytom."},{"key":"B52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/CIRCGENETICS.111.960385","article-title":"Elevated CD14++CD16-monocytes predict cardiovascular events","volume":"5","author":"Berg","year":"2012","journal-title":"Circ Cardiovasc Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5270657","article-title":"Circulating CD14+CD163+CD206+ M2 monocytes are increased in patients with early stage of idiopathic membranous nephropathy","volume":"2018","author":"Hou","year":"2018","journal-title":"Mediators Inflamm."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jama.2011.10","article-title":"Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics","volume":"167","author":"Iannuzzi","year":"2011","journal-title":"JAMA."},{"key":"B55","doi-asserted-by":"publisher","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","article-title":"The soluble interleukin-2 receptor: biology, function, and clinical application","volume":"113","author":"Rubin","year":"1990","journal-title":"Ann Intern Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","article-title":"Mechanism of granuloma formation in sarcoidosis","volume":"24","author":"Sakthivel","year":"2017","journal-title":"Curr Opin Hematol."},{"key":"B57","first-page":"634","article-title":"Role of interleukin-2 release by lung T-cells in active pulmonary sarcoidosis","volume":"218","author":"Hunninghake","year":"1983","journal-title":"Am Rev Respir Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e0223897","DOI":"10.1371\/journal.pone.0223897","article-title":"Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis","volume":"14","author":"Eurelings","year":"2019","journal-title":"PLoS One."},{"key":"B59","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1183\/09031936.00055213","article-title":"Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis","volume":"43","author":"Vorselaars","year":"2014","journal-title":"Eur Respir J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.36141\/svdld.v34i1.5045","article-title":"The clinical value of serum soluble interleukin-2 receptor in pulmonary sarcoidosis","volume":"34","author":"Ogata-Suetsugu","year":"2017","journal-title":"Sarcoidosis Vasc Diffus Lung Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1378\/chest.124.1.186","article-title":"Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation","volume":"124","author":"Grutters","year":"2003","journal-title":"Chest."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","article-title":"Imbalance in B cell and T follicular helper cell subsets in pulmonary sarcoidosis","volume":"10","author":"Kudryavtsev","year":"2020","journal-title":"Sci Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin Mol Allergy."},{"key":"B64","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","article-title":"Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis","volume":"37","author":"Ando","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e43588","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PLoS One."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity","volume":"52","author":"Ueda-Hayakawa","year":"2013","journal-title":"Rheumatology."},{"key":"B67","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/0961203306071871","article-title":"B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time","volume":"15","author":"Becker-Merok","year":"2006","journal-title":"Lupus."},{"key":"B68","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jbspin.2008.01.025","article-title":"Rituximab as a treatment alternative in sarcoidosis","volume":"75","author":"Belkhou","year":"2008","journal-title":"Jt Bone Spine."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1128\/CVI.05118-11","article-title":"Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis","volume":"18","author":"Lee","year":"2011","journal-title":"Clin Vaccine Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","article-title":"Perigranuloma localization and abnormal maturation of B cells emerging key players in sarcoidosis?","volume":"187","author":"Kamphuis","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1084\/jem.185.5.953","article-title":"NF-\u03baB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses","volume":"185","author":"Doi","year":"1997","journal-title":"J Exp Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/1346-8138.13792","article-title":"Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement","volume":"44","author":"Thi Hong Nguyen","year":"2017","journal-title":"J Dermatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cca.2019.10.010","article-title":"Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis","volume":"500","author":"Enyedi","year":"2020","journal-title":"Clin Chim Acta."},{"key":"B75","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/00365510701854975","article-title":"Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity","volume":"68","author":"Bargagli","year":"2008","journal-title":"Scand J Clin Lab Invest."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1378\/chest.09-1975","article-title":"Comparative evaluation of serum markers in pulmonary sarcoidosis","volume":"137","author":"Miyoshi","year":"2010","journal-title":"Chest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12931-016-0381-0","article-title":"Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients","volume":"17","author":"Hamsten","year":"2016","journal-title":"Respir Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e31103","DOI":"10.5812\/ircmj.31103","article-title":"Bronchoalveolar lavage fluid characteristics of patients with sarcoidosis and nonsarcoidosis interstitial lung diseases: ten-year experience of a single center in turkey","volume":"17","author":"Tanriverdi","year":"2015","journal-title":"Iran Red Crescent Med J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1183\/09031936.00144311","article-title":"Value of s-ACE, BAL lymphocytosis, and CD4+\/CD8+ and CD103+CD4+\/CD4+ T-cell ratios in diagnosis of sarcoidosis","volume":"39","author":"Hyldgaard","year":"2012","journal-title":"Eur Respir J."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1183\/09031936.97.10122699","article-title":"CD4\/CD8 ratios in bronchoalveolar lavage fluid: of value for diagnosing sarcoidosis?","volume":"10","author":"Costabel","year":"1997","journal-title":"Eur Respir J."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1183\/09031936.97.10122716","article-title":"The CD4\/CD8 ratio in BAL fluid is highly variable in sarcoidosis","volume":"10","author":"Kantrow","year":"1997","journal-title":"Eur Respir J."},{"key":"B82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12931-020-1327-0","article-title":"Lung CD4+ V\u03b12","volume":"21","author":"Darlington","year":"2020","journal-title":"Respir Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/labinvest.3780111","article-title":"Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis","volume":"80","author":"Kolopp-Sarda","year":"2000","journal-title":"Lab Investig."},{"key":"B84","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.clim.2007.11.005","article-title":"Evaluation of CD103 as a cellular marker for the diagnosis of pulmonary sarcoidosis","volume":"126","author":"Heron","year":"2008","journal-title":"Clin Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1159\/000446606","article-title":"Diagnostic value of the CD103+CD4+\/CD4+ ratio to differentiate sarcoidosis from other causes of lymphocytic alveolitis","volume":"91","author":"Bretagne","year":"2016","journal-title":"Respiration."},{"key":"B86","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax."},{"key":"B87","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/MCP.0000000000000303","article-title":"T-cell immunology in sarcoidosis: Disruption of a delicate balance between helper and regulatory T-cells","volume":"22","author":"Broos","year":"2016","journal-title":"Curr Opin Pulm Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-\u03b3producing t-helper 17","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1080\/17476348.2019.1655401","article-title":"New concepts in the pathogenesis of sarcoidosis","volume":"13","author":"Bennett","year":"2019","journal-title":"Expert Rev Respir Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"19911","DOI":"10.1002\/jcp.28589","article-title":"Phosphoinositide 3-kinase\/protein kinase B inhibition restores regulatory T cell's function in pulmonary sarcoidosis","volume":"234","author":"Zhang","year":"2019","journal-title":"J Cell Physiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaut.2018.07.012","article-title":"Molecular profiling of regulatory T cells in pulmonary sarcoidosis","volume":"94","author":"Kachamakova-Trojanowska","year":"2018","journal-title":"J Autoimmun."},{"key":"B92","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10875-008-9225-0","article-title":"Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis","volume":"29","author":"Wik\u00e9n","year":"2009","journal-title":"J Clin Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1164\/rccm.200909-1451OC","article-title":"Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis","volume":"182","author":"Prasse","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.chest.2017.11.030","article-title":"The pathogenesis of pulmonary sarcoidosis and implications for treatment","volume":"153","author":"Patterson","year":"2018","journal-title":"Chest."},{"key":"B95","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/cyto.b.20120","article-title":"Prognostic value of neutrophils and NK cells in bronchoalveolar lavage of sarcoidosis","volume":"70","author":"Tutor-Ureta","year":"2006","journal-title":"Cytom Part B Clin Cytom."},{"key":"B96","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s10238-019-00578-3","article-title":"NK and NKT-like cells in granulomatous and fibrotic lung diseases","volume":"19","author":"Bergantini","year":"2019","journal-title":"Clin Exp Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nri3725","article-title":"Natural killer T cells: Drivers or passengers in preventing human disease?","volume":"14","author":"Berzins","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1378\/chest.10-0188","article-title":"Recent advances in sarcoidosis","volume":"139","author":"Morgenthau","year":"2011","journal-title":"Chest."},{"key":"B99","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/intimm\/dxh020","article-title":"Impaired IFN-\u03b3 production of V\u03b124 NKT cells in non-remitting sarcoidosis","volume":"16","author":"Kobayashi","year":"2004","journal-title":"Int Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.rmed.2009.11.008","article-title":"Deficiency of pulmonary V\u03b124 V\u03b211 natural killer T cells in corticosteroid-na\u00efve sarcoidosis patients","volume":"104","author":"Korosec","year":"2010","journal-title":"Respir Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0140-6736(05)71143-0","article-title":"Deficiency of a subset of T-cells with immunoregulatory properties in sarcoidosis","volume":"365","author":"Ho","year":"2005","journal-title":"Lancet."},{"key":"B102","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1183\/09031936.00157508","article-title":"CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis","volume":"34","author":"Busuttil","year":"2009","journal-title":"Eur Respir J."},{"key":"B103","doi-asserted-by":"publisher","first-page":"105822","DOI":"10.1016\/j.rmed.2019.105822","article-title":"CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis","volume":"161","author":"Arger","year":"2020","journal-title":"Respir Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.rmed.2019.04.005","article-title":"Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis","volume":"152","author":"Arger","year":"2019","journal-title":"Respir Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5588\/ijtld.14.0525","article-title":"CXCR3 ligands as clinical markers for pulmonary tuberculosis","volume":"19","author":"Lee","year":"2015","journal-title":"Int J Tuberc Lung Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.5588\/ijtld.15.0325","article-title":"Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis","volume":"19","author":"Chung","year":"2015","journal-title":"Int J Tuberc Lung Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1378\/chest.96.1.68","article-title":"New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6","volume":"96","author":"Kohno","year":"1989","journal-title":"Chest."},{"key":"B108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.15406\/mojcrr.2018.01.00009","article-title":"Serum krebs von den lungen-6 (KL-6): a promising biomarker in sarcoidosis","volume":"1","author":"Menon","year":"2018","journal-title":"MOJ Curr Res Rev."},{"key":"B109","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","article-title":"KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease","volume":"148","author":"Kohno","year":"1993","journal-title":"Am Rev Respir Dis."},{"key":"B110","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1159\/000050556","article-title":"KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis","volume":"68","author":"Kunitake","year":"2001","journal-title":"Respiration."},{"key":"B111","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1378\/chest.124.6.2119","article-title":"Study of clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis","volume":"124","author":"Janssen","year":"2003","journal-title":"Chest."},{"key":"B112","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10238-020-00608-5","article-title":"BAL biomarkers' panel for differential diagnosis of interstitial lung diseases","volume":"20","author":"D'Alessandro","year":"2020","journal-title":"Clin Exp Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ccm.2015.08.004","article-title":"Chest imaging","volume":"36","author":"Keijsers","year":"2015","journal-title":"Clin Chest Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br Med J."},{"key":"B116","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12016-015-8478-7","article-title":"Imaging of sarcoidosis","volume":"49","author":"Silva","year":"2015","journal-title":"Clin Rev Allergy Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest."},{"key":"B118","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1378\/chest.08-1876","article-title":"Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation","volume":"136","author":"Baughman","year":"2009","journal-title":"Chest."},{"key":"B119","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1440-1843.2007.01206.x","article-title":"The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis","volume":"13","author":"Judson","year":"2008","journal-title":"Respirology."},{"key":"B120","first-page":"65","article-title":"Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography","volume":"14","author":"Oberstein","year":"1997","journal-title":"Sarcoidosis Vasc Diffus Lung Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1007\/s00330-003-1965-x","article-title":"Sarcoidosis: assessment of disease severity using HRCT","volume":"13","author":"Drent","year":"2003","journal-title":"Eur Radiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-2466-12-57","article-title":"A predictive tool for an effective use of 18F-FDG PET in assessing activity of sarcoidosis","volume":"12","author":"Mostard","year":"2012","journal-title":"BMC Pulm Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/thoraxjnl-2016-208833","article-title":"CTAS: A CT score to quantify disease activity in pulmonary sarcoidosis","volume":"71","author":"Benamore","year":"2016","journal-title":"Thorax."},{"key":"B124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/MD.0000000000012205","article-title":"Relationship between CT activity score with lung function and the serum angiotensin converting enzyme in pulmonary sarcoidosis on chest HRCT","volume":"97","author":"Duan","year":"2018","journal-title":"Medicine (Baltimore)."},{"key":"B125","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/s-0034-1376866","article-title":"FDG PET for gauging of sarcoid disease activity","volume":"35","author":"Adams","year":"2014","journal-title":"Semin Respir Crit Care Med."},{"key":"B126","unstructured":"Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis15716\n            NishiyamaY\n            YamamotoY\n            FukunagaK\n            TakinamiH\n            IwadoY\n            SatohK\n          17015889J Nucl Med.472006"},{"key":"B127","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4081\/itjm.2012.21","article-title":"Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: A systematic review","volume":"28","author":"Treglia","year":"2011","journal-title":"Sarcoidosis Vasc Diffus Lung Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00259-009-1097-x","article-title":"18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis","volume":"36","author":"Keijsers","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B129","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2018\/1823710","article-title":"The utility of 18F-FDG PET\/CT for monitoring response and predicting prognosis after glucocorticoids therapy for sarcoidosis","volume":"2018","author":"Chen","year":"2018","journal-title":"Biomed Res Int."},{"key":"B130","unstructured":"Extent of disease activity assessed by 18F-FDG PET\/CT in a Dutch sarcoidosis population3745\n            CremersJP\n            Van KroonenburghMJ\n            MostardRLM\n            V\u00f6\u00f6SA\n            WijnenPA\n            KoekGH\n          24751452Sarcoidosis Vasc Diffus Lung Dis.312014"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1378\/chest.07-1178","article-title":"Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis","volume":"132","author":"Teirstein","year":"2007","journal-title":"Chest."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med."},{"key":"B133","unstructured":"18F-FDG PET as a predictor of pulmonary function in sarcoidosis1239\n            KeijsersRG\n            VerzijlbergenFJ\n            Van Den BoschJM\n            ZanenP\n            VanDe Garde EM\n            OyenWJ\n          22117503Sarcoidosis Vasc Diffus Lung Dis.282011"},{"key":"B134","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1183\/09031936.00227014","article-title":"Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis","volume":"46","author":"Vorselaars","year":"2015","journal-title":"Eur Respir J."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2967\/jnumed.112.104380","article-title":"The utility of 18F-FDG PET\/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis","volume":"53","author":"Sobic-Saranovic","year":"2012","journal-title":"J Nucl Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"44","DOI":"10.36141\/svdld.v35i1.5807","article-title":"Volumetric FDG PET analysis of global lung inflammation: new tool for precision medicine in pulmonary sarcoidosis?","volume":"35","author":"Adams","year":"2018","journal-title":"Sarcoidosis Vasc Diffus Lung Dis."},{"key":"B137","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13550-019-0505-x","article-title":"Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET\/CT: SUVmax versus total lung glycolysis","volume":"9","author":"Schimmelpennink","year":"2019","journal-title":"EJNMMI Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MCP.0000000000000410","article-title":"Cardiac sarcoidosis: challenges in clinical practice","volume":"23","author":"Bakker","year":"2017","journal-title":"Curr Opin Pulm Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/eurheartj\/ehw328","article-title":"Cardiac manifestations of sarcoidosis: diagnosis and management","volume":"38","author":"Birnie","year":"2017","journal-title":"Eur Heart J."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Hear Rhythm."},{"key":"B141","doi-asserted-by":"publisher","first-page":"e005022","DOI":"10.1161\/CIRCIMAGING.116.005022","article-title":"Comprehensive cardiovascular magnetic resonance assessment in patients with sarcoidosis and preserved left ventricular ejection fraction","volume":"9","author":"Greulich","year":"2016","journal-title":"Circ Cardiovasc Imaging."},{"key":"B142","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"JACC Cardiovasc Imaging."},{"key":"B143","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/ehjci\/jeu294","article-title":"Late gadolinium enhancement identified with cardiac magnetic resonance imaging in sarcoidosis patients is associated with long-term ventricular arrhythmia and sudden cardiac death","volume":"16","author":"Nadel","year":"2015","journal-title":"Eur Hear J Cardiovasc Imaging."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B145","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B146","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijcard.2017.03.033","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"241","author":"Bravo","year":"2017","journal-title":"Int J Cardiol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","article-title":"The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoid","volume":"23","author":"Manabe","year":"2016","journal-title":"J Nucl Cardiol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1097\/RLU.0000000000001063","article-title":"Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis a systematic review and meta-analysis","volume":"41","author":"Tang","year":"2016","journal-title":"Clin Nucl Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"e007030","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging."},{"key":"B150","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jcmg.2017.02.021","article-title":"Hybrid magnetic resonance imaging and positron emission tomography with fluorodeoxyglucose to diagnose active cardiac sarcoidosis","volume":"11","author":"Dweck","year":"2018","journal-title":"JACC Cardiovasc Imaging."},{"key":"B152","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1474-4422(04)00805-1","article-title":"Neurosarcoidosis: a clinical dilemma","volume":"3","author":"Hoitsma","year":"2004","journal-title":"Lancet Neurol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s00415-005-0043-5","article-title":"Neurosarcoidosis: clinical description of 7 cases with a proposal for a new diagnostic strategy","volume":"253","author":"Marangoni","year":"2006","journal-title":"J Neurol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","article-title":"Central nervous system sarcoidosis-diagnosis and management","volume":"92","author":"Zajicek","year":"1999","journal-title":"QJM Mon J Assoc Physicians."},{"key":"B155","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.crad.2015.09.007","article-title":"Imaging of neurosarcoidosis: common, uncommon, and rare","volume":"71","author":"Bathla","year":"2016","journal-title":"Clin Radiol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00408-019-00206-7","article-title":"The burden of sarcoidosis symptoms from a patient perspective","volume":"197","author":"Voortman","year":"2019","journal-title":"Lung."},{"key":"B157","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-0030-1262210","article-title":"Neurosarcoidosis: diagnosis and management","volume":"31","author":"Vargas","year":"2010","journal-title":"Semin Respir Crit Care Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1212\/WNL.0b013e3182684672","article-title":"MRI and PET imaging discordance in neurosarcoidosis","volume":"79","author":"Huang","year":"2012","journal-title":"Neurology."},{"key":"B159","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/brainsci9100243","article-title":"Value of multimodal imaging approach to diagnosis of neurosarcoidosis","volume":"9","author":"Sammarra","year":"2019","journal-title":"Brain Sci."},{"key":"B160","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/qjmed\/hcz148","article-title":"Neurosarcoidosis and infliximab therapy monitored by 18FDG PET\/CT","volume":"112","author":"Rivi\u00e8re","year":"2019","journal-title":"QJM."},{"key":"B161","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","article-title":"Hypothesis: Sarcoidosis is a STAT1-mediated disease","volume":"132","author":"Rosenbaum","year":"2009","journal-title":"Clin Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jdcr.2019.02.006","article-title":"Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera","volume":"5","author":"Wei","year":"2019","journal-title":"JAAD Case Rep."},{"key":"B164","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jaad.2019.05.098","article-title":"Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare","volume":"82","author":"Damsky","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky","year":"2018","journal-title":"N Engl J Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1801482","DOI":"10.1183\/13993003.01482-2018","article-title":"Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia","volume":"52","author":"Rotenberg","year":"2018","journal-title":"Eur Respir J."},{"key":"B167","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"MTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell."},{"key":"B168","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1900430","DOI":"10.1183\/13993003.00430-2019","article-title":"Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis","volume":"54","author":"Calender","year":"2019","journal-title":"Eur Respir J."},{"key":"B170","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1378\/chest.10-2629","article-title":"Characterization of chronic fatigue in patients with sarcoidosis in clinical remission","volume":"140","author":"Korenromp","year":"2011","journal-title":"Chest."},{"key":"B171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0215763","article-title":"Scalp hair cortisol and testosterone levels in patients with sarcoidosis","volume":"14","author":"Van Manen","year":"2019","journal-title":"PLoS One."},{"key":"B172","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.psyneuen.2011.09.009","article-title":"Hair cortisol as a biological marker of chronic stress: Current status, future directions and unanswered questions","volume":"37","author":"Russell","year":"2012","journal-title":"Psychoneuroendocrinology."},{"key":"B173","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer 68Ga-DOTANOC PET\/CT and 18F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1183\/13993003.01352-2015","article-title":"99mTc-anti-TNF-\u03b1 antibody for the imaging of disease activity in pulmonary sarcoidosis","volume":"47","author":"Vis","year":"2016","journal-title":"Eur Respir J"},{"key":"B175","doi-asserted-by":"publisher","first-page":"l5553","DOI":"10.1136\/bmj.l5553","article-title":"New advances in the management of pulmonary sarcoidosis","volume":"367","author":"Culver","year":"2019","journal-title":"BMJ."},{"key":"B176","doi-asserted-by":"publisher","first-page":"A4489","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A4489","article-title":"Proteomic profiling of serum exosomes to find novel biomarkers in sarcoidosis","volume":"201","author":"Futami","year":"2020","journal-title":"Am J Respir Crit Care Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01443\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T02:49:36Z","timestamp":1594694976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01443\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":176,"alternative-id":["10.3389\/fimmu.2020.01443"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01443","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"article-number":"1443"}}